Inflammasome biology in preeclampsia: from Bnip3-mitophagy to Nlrp1-driven placental injury - a systematic review and translational roadmap.

In 30 seconds

This PRISMA 2020 systematic review synthesized experimental, observational, and mechanistic studies of mitochondrial quality control and inflammasome signaling in preeclampsia. Across 31 eligible studies, the authors describe a pathway in which dysregulated BNIP3-mediated mitophagy and rising mitochondrial reactive oxygen species may converge on NLRP1 activation and trophoblast injury. The review argues that mitochondrial injury may be a central contributor to the inflammatory cascade, rather than merely a by-product, while noting that evidence for the proposed BNIP3–mtROS–NLRP1 axis is fragmented and comes from heterogeneous models.

Key findings

• The review included 31 eligible studies spanning experimental, observational, and mechanistic evidence.
• Dysregulated BNIP3-mediated mitophagy and mitochondrial ROS were linked to NLRP1 activation and trophoblast injury.
• The authors identify mitochondrial injury as a potential central instigator of the inflammatory cascade associated with preeclampsia.

Why it matters

The review broadens the mechanistic account of preeclampsia beyond the NLRP3-focused framing, highlighting possible links between placental mitochondrial dysfunction and NLRP1 signaling. This synthesis may help guide research into how mitochondrial quality control and inflammatory pathways interact, while the heterogeneous and fragmented evidence means the proposed pathway should be viewed as a mechanistic framework rather than an established clinical target.

What to keep in mind

The authors note that evidence for the proposed pathway is fragmented and derived from heterogeneous models.